ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ADGI Adagio Therapeutics Inc

4.64
0.00 (0.00%)
After Hours
Last Updated: 20:00:00
Delayed by 15 minutes

Adagio Therapeutics Financial Summary

The current ADGI market cap is 510.93M. The company's latest EPS is USD -1.8040 and P/E is -1.14.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -47.33M-30.84M-39.07M-53.88M-43.06M
Net Income -45.09M-44.57M-35.32M-50.23M-39.44M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -226.91M-230.66M-212.76M
Net Income -226.79M-241.32M-198.64M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Total Assets 424.75M383.17M350.56M315.41M274.92M
Total Liabilities 47.3M27.2M23.82M33.85M28.42M
Total Equity 377.44M355.97M326.75M281.56M246.5M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 620.09M383.17M229.18M
Total Liabilities 62.07M27.2M51.71M
Total Equity 558.02M355.97M177.47M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)
Operating -172.58M-219.99M-41.18M-78.57M-113.92M
Investing -91.85M-230.67M75.04M107.63M202.77M
Financing 365k506k542k812k904k
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -184.74M-219.99M-173.16M
Investing -50.71M-230.67M280.68M
Financing 662.68M506k1.05M
Market Cap 510.93M
Price to Earnings Ratio -1.14
Price to Sales Ratio 0
Price to Cash Ratio 1.13
Price to Book Ratio 1.28
Dividend Yield -

Share Statistics

Shares Outstanding 110.12M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.22 (4.64%)

Company Info

Company Name Adagio Therapeutics Inc
Address corporation trust center
wilmington, delaware 19801
Website https://invivyd.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock